# Pine Pharmaceuticals, LLC, Tonawanda, NY – FDA Inspections

Source: https://www.keypedia.com/companies/pine-pharmaceuticals-llc/03870efc-b074-462a-8520-e5cadc945149

> Inspection records and compliance data for Pine Pharmaceuticals, LLC in Tonawanda, New York. 7 FDA inspections on record (4 OAI), 4 Form 483s, 1 warning letter, last inspected November 14, 2025.

---

## Details

- Name: Pine Pharmaceuticals, LLC
- FEI Number: 3010943533
- Facility Type: Outsourcing Facility
- Address Line 1: 355 Riverwalk Pkwy
- City: Tonawanda
- State: New York
- Zip Code: 14150
- Country Name: United States
- Address: 355 Riverwalk Pkwy, Tonawanda, New York 14150, United States
- Country: United States

## Related Documents

- [WARNING_LETTER - Pine Pharmaceuticals, LLC - 2025-11-14](https://www.keypedia.com/records/warning_letter/pine-pharmaceuticals-llc/76339eae-7640-49ee-bab6-02393b94859d) — source: FDA, date: November 14, 2025
- [FDA Inspection 1282102 - Pine Pharmaceuticals, LLC - 2025-11-14](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/e52bd9ac-947a-43f2-b278-af277e538e07) — source: FDA, date: November 14, 2025
- [483 - Pine Pharmaceuticals, LLC - 2025-11-04](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/240a895f-286f-4838-8c79-b871f8d4bdc6) — source: FDA, date: November 4, 2025
- [483 - Pine Pharmaceuticals, LLC - 2024-09-30](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/61efa7fb-c465-4751-8312-aee5e5755f10) — source: FDA, date: September 30, 2024
- [FDA Inspection 1246936 - Pine Pharmaceuticals, LLC - 2024-09-30](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/b26b3e1e-7f23-4119-bccc-18b78849777b) — classification: Official Action Indicated (OAI), source: FDA, date: September 30, 2024
- [483 - Pine Pharmaceuticals, LLC - 2023-09-19](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/3c7b832f-d00c-40e1-9678-fd3f0822759f) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218206 - Pine Pharmaceuticals, LLC - 2023-09-19](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/22f4e0f7-f43d-455f-8d62-ad77733fc626) — classification: Official Action Indicated (OAI), source: FDA, date: September 19, 2023
- [483 - Pine Pharmaceuticals, LLC - 2021-05-14](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/9fc4c1f8-9b94-4754-a9bc-05e72748fcda) — source: FDA, date: May 14, 2021
- [FDA Inspection 1141929 - Pine Pharmaceuticals, LLC - 2021-05-14](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/1ef3f8d9-d6da-4178-8af3-44d2818de3d4) — classification: Official Action Indicated (OAI), source: FDA, date: May 14, 2021
- [483 - Pine Pharmaceuticals, LLC - 2018-04-26](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/55e7005d-6d26-4d42-b03a-0e8ce4098bc6) — source: FDA, date: April 26, 2018
- [FDA Inspection 1049641 - Pine Pharmaceuticals, LLC - 2018-04-26](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/0f8a59f1-ed7f-4ae2-9b0b-4ca6b4758585) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 26, 2018
- [483 - Pine Pharmaceuticals, LLC - 2015-10-09](https://www.keypedia.com/records/483/pine-pharmaceuticals-llc/67e03907-7b59-481f-9c54-e7e42c2cbbbb) — source: FDA, date: October 9, 2015
- [FDA Inspection 945292 - Pine Pharmaceuticals, LLC - 2015-10-09](https://www.keypedia.com/records/fda_inspections/pine-pharmaceuticals-llc/6448b238-23e1-4acc-9f0d-6989b3b49301) — classification: Official Action Indicated (OAI), source: FDA, date: October 9, 2015
- FDA Inspection 900138 - Pine Pharmaceuticals, LLC - 2014-10-17 — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2014

## Related Companies

- [Ohm Laboratories, Inc.](https://www.keypedia.com/companies/ohm-laboratories-inc/8d38ef3a-8c55-47c4-89b4-f5fe41d851e8)
- [Michael T. Lin, M.D.](https://www.keypedia.com/companies/michael-t-lin-md/6051da9e-5438-4803-a467-0352ece7f1e0)
- [J. John Mann, M.D.](https://www.keypedia.com/companies/j-john-mann-md/e448ff32-7899-4a8b-872b-f0796d80fae8)
- [Park Irmat Drug Corp., dba Irmat Pharmacy](https://www.keypedia.com/companies/park-irmat-drug-corp-dba-irmat-pharmacy/9a847a5f-07c7-4b81-aa1c-861e36c4b665)
- [Jonathan E. Rosenberg, MD](https://www.keypedia.com/companies/jonathan-e-rosenberg-md/10ebdfec-1adf-44df-8030-15f9a2eb3c20)
- [Rogerio Lobo](https://www.keypedia.com/companies/rogerio-lobo/5b228f74-af60-4bea-b969-fddd5ae4963f)
- [Athenex, Inc.](https://www.keypedia.com/companies/athenex-inc/be1cdf97-cc70-481c-b6c3-9f409adcb4d1)
- [Arnot Health IRB](https://www.keypedia.com/companies/arnot-health-irb/34a8e424-18a9-4951-b1d6-6319b6c5f604)
- [Scott Bloom, M.D.](https://www.keypedia.com/companies/scott-bloom-md/58ec7f36-ef71-4a29-9660-3f303447c409)
- [Jens Hillengass, M.D., Ph.D.](https://www.keypedia.com/companies/jens-hillengass-md-phd/8aa89042-e542-4bf3-acf2-b0b64b302d32)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/james-a-liubicich/31b3dad6-b187-458c-8f13-dcf9a758a28b)
- [Mindy M. Chou](https://www.keypedia.com/people/mindy-m-chou/3d0e74bf-ad6b-48b5-8b72-cbb29e9c9ce5)
- [Investigator](https://www.keypedia.com/people/rachael-a-moliver/6130c1d8-9867-4da5-b113-1bbaf0ae9c79)
- [Johnna L. Bleem](https://www.keypedia.com/people/johnna-l-bleem/3fe669bf-e354-4cdc-9337-d5ceb23f1c9f)